PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Immunology Department, LHUB-ULB, Université libre de Bruxelles (ULB), Brussels, Belgium.\', \'Department of Infectious Diseases, Centre Hospitalier Universitaire Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium.\', \'Institute for Medical Immunology, Université libre de Bruxelles (ULB), Brussels, Belgium.\', \'Department of Infectious Disease, Brugmann University Hospital, Brussels, Belgium.\', \'Ars Statistica, Brussels, Belgium.\', \'Department of Intensive Care, Centre Hospitalier Universitaire Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium.\', \'Clinical Research Department, Brugmann University Hospital, Brussels, Belgium.\', \'Department of Intensive Care, Brugmann University Hospital, Brussels, Belgium.\', \'Laboratory of Translational Research, Brugmann University Hospital, Université libre de Bruxelles (ULB), Brussels, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1089/vim.2021.0111
?:doi
?:hasPublicationType
?:journal
  • Viral immunology
is ?:pmid of
?:pmid
?:pmid
  • 35085462
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.677
?:rankingScore_hIndex
  • 56
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6.
?:type

Metadata

Anon_0  
expand all